RAND Europe is providing research and support for the European Centre for Disease Prevention and Control (ECDC) for the assessment of new technologies for infectious disease surveillance, prevention and control over the next two years.
Research into up-and-coming technologies is intended help to improve situational awareness and inform the coordination of the European Centre for Disease Prevention and Control (ECDC)’s infection control in response to outbreak events.
Electronic health records (EHR) data could greatly help infectious disease surveillance, but their use varies across Europe. Researchers are mapping EHR use to assess the feasibility of using EHR data for infectious disease surveillance.
Researchers are examining the availability of point-of-care testing (POCT) devices to diagnose the 56 communicable diseases and related health issues currently under EU surveillance, and mapping trends in the use of POCT in Europe.
For three years, RAND Europe has supported AIA Vitality's contest. Doing so enables researchers to explore the health trends—employee lifestyle, clinical indicators, mental health and other areas of concern—among participating Asia-Pacific workplaces.
To prepare for the implementation of a pilot scheme to pay for cancer drugs based on achieved outcomes, researchers are addressing issues identified in the first phase of research, such as the quality and completeness of real-world data on key patient outcomes.
RAND Europe’s growing work in the field of mental health and wellbeing draws on expertise from across a range of disciplines and methodological backgrounds to bring an innovative perspective to our projects. In particular, our well-established reputation in healthcare research is complemented by extensive science policy expertise, particularly in the field of research evaluation.
Researchers are examining the factors that enable or hinder the implementation of workplace health and wellbeing practices. The research will consider whether certain combinations of practices are more effective than other combinations, or effective for some types of organisations and not others.
RAND Europe is conducting a four-year, independent evaluation of the second phase of the Q Initiative to help guide the learning of the Q project team and wider stakeholders as they continue their implementation of Q across the UK. The research will support strategic decision-making and inform the ongoing design and management of Q and also assess the initiative's impact.
The Birmingham, RAND and Cambridge Evaluation (BRACE) Centre is funded by the National Institute for Health Research (NIHR) to conduct rapid evaluations of promising new services and innovations in healthcare.
Researchers are examining complex and enduring policy issues that have implications for public health (climate change and tobacco control) to gain a new perspective on how to tackle AMR. The team will look at how historical analysis can be used in future approaches to scenario planning and policymaking, with a particular focus on AMR policy.
Innovation Fund Health-led Trials test new ways to address sickness absence and the disability employment gap due to two main conditions: mental health and musculoskeletal disorders. RAND Europe, together with partners, is evaluating the effectiveness of these innovative interventions.
In the NHS, patients with musculoskeletal conditions currently need to see a GP before visiting a physiotherapist. As part of a larger project for Arthritis Research UK, RAND Europe addresses the question as to whether patient direct access to physiotherapy would be cost-effective.
A comprehensive survey of staff health and wellbeing at a selection of NHS organisations will map in detail the physical and mental health of NHS staff as well as their perceptions of existing work-wellbeing initiatives and organisational culture.